Anticancer Therapies – News and Features

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with pancreatic cancer.

An oral vaccine against recurrent UTIs could reduce the need for antibiotic treatment.

A new “atlas” of the human ovary provides insights that could lead to treatments restoring ovarian hormone production and the ability to have biologically related children, according to University of Michigan engineers.

Chemists have created a new collection of molecular compounds and begun testing them as potential leads in the search for new drugs. Among these molecules, they found several that show promise for development as antibiotics and cancer therapies.

A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, providing more personalized treatment to patients.

Mayo Clinic scientists have developed an immunotherapy strategy that utilizes CAR-MSCs. The approach shows potential in targeting inflammatory disease sites more precisely and improving immunosuppression and healing outcomes.

Cancer cells release a significantly more concentrated level of acid than previously known, forming an “acid wall” that could deter immune cells from attacking tumors, UT Southwestern Medical Center scientists show in a new study.

University of California San Diego scientists reporting in the journal Science have found a key mechanism that keeps track of mitosis timing and takes note when the process takes too long.

Researchers have developed and validated a machine-learning model that can accurately evaluate the density of surviving tumor cells after treatment.

Two separate studies have delved into the understanding of resistance to chemotherapy in TNBC and found new ways to segment patients and improve treatment from it.